Cristina White - GRI Bio Interim Officer

All Insiders USA . 
Etf . GRI Bio . Stakeholders . Insider . Cristina White
GRI Etf  USD 0.74  0.05  7.25%   
Cristina White is Portfolio Manager at GRI Bio
Address 2223 Avenida de la Playa, LA Jolla, CA, United States, 92037
Phone619 400 1170
Webhttps://www.gribio.com

GRI Bio Management Efficiency

The company has Return on Asset of (0.8253) % which means that on every $100 spent on assets, it lost $0.8253. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.8906) %, meaning that it generated no profit with money invested by stockholders. GRI Bio's management efficiency ratios could be used to measure how well GRI Bio manages its routine affairs as well as how well it operates its assets and liabilities.
GRI Bio has 14 K in debt with debt to equity (D/E) ratio of 1.23, which is OK given its current industry classification. GRI Bio has a current ratio of 5.13, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist GRI Bio until it has trouble settling it off, either with new capital or with free cash flow. So, GRI Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like GRI Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for GRI to invest in growth at high rates of return. When we think about GRI Bio's use of debt, we should always consider it together with cash and equity.

Similar Fund Executives

Showing other executives

One Year Return

Bob LallyIkena Oncology
N/A
Courtney SolbergC4 Therapeutics
N/A
Rebecca CohenIkena Oncology
N/A
William MDPrelude Therapeutics
N/A
MBA IIICelcuity LLC
63
Christopher NasveschukC4 Therapeutics
N/A
Philip JDMonte Rosa Therapeutics
45
Brent EilefsonCelcuity LLC
N/A
Katarina MDXilio Development
48
Madhu PudipeddiPrelude Therapeutics
N/A
John JDEdgewise Therapeutics
60
Mustapha ParekhDesign Therapeutics
N/A
Jolie JDC4 Therapeutics
47
Srikanth MDConnect Biopharma Holdings
N/A
Andrew FunderburkMonte Rosa Therapeutics
N/A
Sue BrownePassage Bio
N/A
Eden FucciPassage Bio
N/A
Gregory FuestPassage Bio
N/A
Scott ColemanXilio Development
N/A
Mark MosslerC4 Therapeutics
51
Kevin BrennanXilio Development
54
The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses, of an index called the Cohen Steers Global Realty Majors Index. Cohen Steers is traded on Archipelago Exchange in USA. GRI Bio [GRI] is traded in USA and was established 2008-05-07. GRI Bio is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Return On Equity-1.89
Return On Asset-0.83

GRI Bio Money Managers

Cristina White, Interim Officer
Albert Agro, CoFounder Officer
Marc Hertz, President Director
Vipin Chaturvedi, CoFounder Officer
Leanne Kelly, CFO Secretary

GRI Etf Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is GRI Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.89
Return On Asset-0.83
Current Valuation1.99 M
Shares Outstanding8.93 M
Shares Owned By Insiders0.35 %
Shares Owned By Institutions4.70 %
Number Of Shares Shorted924.63 K
Price To Earning23.35 X
Price To Book1.80 X
Revenue21.77 M

Currently Active Assets on Macroaxis

RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
SSentinelOne
WDWalker Dunlop

Other Information on Investing in GRI Etf

GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY